Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-22 · accession 0001104659-22-093748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-23 | 2022-08-22 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | M - OptEx | $7.90 | +5,000 | 92.2K | +6% | +$39.5K |
| D | 2022-08-23 | 2022-08-22 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | S - Sale+OE | $35.98 | -5,000 | 87.2K | -5% | -$179.9K |
| D | 2022-08-23 | 2022-08-22 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-22 | M | A | 5,000 | $7.90 | 92,220 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-22 | S | D | 5,000 | $35.98 | 87,220 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2022-08-22 | M | D | 5,000 | $0.00 | 0 | D | $7.90 · — to 2023-02-05 | 5,000 Common Stock | (F2) The option vested in four equal annual installments beginning on February 5, 2014. |